UH3 Phase - Mindfulness-Based Blood Pressure Reduction (MB-BP) : Stage 2a RCT

Completed · Not applicable

Conditions studied: Hypertension, Prehypertension

In brief

The primary aim is to identify the impacts of a behavioral intervention called "Mindfulness-Based Blood Pressure Reduction" (MB-BP) vs. enhanced usual care on the primary self-regulation target, specifically an assay of self-related processes (Multidimensional Assessment of Interoceptive Awareness) (MAIA) at 6 months, via a randomized controlled trial.

Key facts

Study ID

NCT03859076

Run by

Brown University

People needed

119

Starts

2018-12-13

Expected to finish

2020-11-12

Last updated by the study team

2021-01-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Elevated blood pressure or hypertension defined as ≥120 mmHg systolic or ≥80 mmHg diastolic pressure.
• Able to speak, read, and write in English.
• All adults (≥18 years of age), genders and racial/ethnic groups are eligible to be included.

You may not qualify if…

• Exclusion criteria follow standard guidelines and recommendations:
• current regular mindfulness meditation practice (>once/week)
• serious medical illness or cognitive condition (e.g., dementia) precluding regular class attendance and/or participation
• current substance abuse, suicidal ideation or eating disorder
• history of bipolar or psychotic disorders or self-injurious behaviors.

Where it is running

• Brown Mindfulness Center — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.